The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Piramal Life Science

Phase I trial of the CDK 4/6 inhibitor, P1446A-05 (voruciclib) in combination with the BRAF inhibitor (BRAFi), vemurafenib in advanced, BRAF-mutant melanoma.
 
Adi Diab
Consulting or Advisory Role - Celgene; Nektar
Research Funding - Celgene (Inst)
 
Alison Martin
No Relationships to Disclose
 
Lauren Simpson
No Relationships to Disclose
 
Alain Patrick Algazi
No Relationships to Disclose
 
Purvi Chawla
Employment - Piramal Life Science
 
Dae Won Kim
No Relationships to Disclose
 
Sourav Santra
Employment - Piramal Life Science
 
Vruti Patel
No Relationships to Disclose
 
Nitin Jadhav
Employment - Piramal Life Science
 
Dhiraj Abhyankar
No Relationships to Disclose
 
Michael A. Davies
Consulting or Advisory Role - Genentech/Roche; GlaxoSmithKline; Novartis; Sanofi
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Myriad Genetics (Inst); Oncothyreon (Inst); Sanofi (Inst)
 
Shama C. Buch
Employment - Piramal Life Science
 
Kevin Kim
Honoraria - Genentech/Roche; GlaxoSmithKline; Novartis
Consulting or Advisory Role - Genentech/Roche; GlaxoSmithKline; Novartis
Research Funding - AstraZeneca (Inst); Eisai (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
 
Adil Daud
Stock and Other Ownership Interests - Oncosec
Consulting or Advisory Role - GlaxoSmithKline; Merck; Oncosec
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck/Schering Plough (Inst); oncosec (Inst); Pfizer (Inst)